| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911042 | Lung Cancer | 2013 | 6 Pages |
Abstract
Gefitinib is a P-gp substrate and has limited active BBB penetration. Increased doses of gefitinib potentially accelerated passive permeability.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Yan Chen, Mengzhao Wang, Wei Zhong, Jing Zhao,